Journal of Antimicrobial Chemotherapy, 1460-2091

Journal

More filtering options
  1. 2019
  2. Defining optimal dosing of ciprofloxacin in patients with septic shock

    Roberts, J. A., Alobaid, A. S., Wallis, S. C., Perner, A., Lipman, J. & Fredrik Sjövall, 2019, In : The Journal of antimicrobial chemotherapy. 74, 6, p. 1662-1669 8 p.

    Research output: Contribution to journalArticle

  3. 2018
  4. Maximally effective dosing regimens of meropenem in patients with septic shock

    Fredrik Sjövall, Alobaid, A. S., Wallis, S. C., Perner, A., Lipman, J. & Roberts, J. A., 2018 Jan 1, In : Journal of Antimicrobial Chemotherapy. 73, 1, p. 191-198 8 p., dkx330.

    Research output: Contribution to journalArticle

  5. Comparison of antibiotic prescribing and antimicrobial resistance in urinary tract infections at the municipal level among women in two Nordic regions

    Jensen, J. N., Eva Melander, Katarina Hedin, Bjerrum, L., Helena Kornfält Isberg, Holm, A., Jacobsen, H. N., Skovby, A., Currea, G. C. C., Hyllebusk, L., Brogaard, E. & Arpi, M., 2018, In : Journal of Antimicrobial Chemotherapy. 73, 8, p. 2207-2214 8 p.

    Research output: Contribution to journalArticle

  6. 2016
  7. Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART

    Lambert-Niclot, S., George, E. C., Pozniak, A., White, E., Schwimmer, C., Jessen, H., Johnson, M., Dunn, D., Perno, C. F., Clotet, B., Plettenberg, A., Blaxhult, A., Palmisano, L., Wittkop, L., Calvez, V., Marcelin, A. G., Raffi, F., Dedes, N., Chěne, G., Allavena, C. & 31 othersAutran, B., Antinori, A., Bucciardini, R., Vella, S., Horban, A., Arribas, J., Babiker, A. G., Boffito, M., Pillay, D., Pozniak, A., Franquet, X., Schwarze, S., Grarup, J., Fischer, A., Richert, L., Wallet, C., Raffi, F., Diallo, A., Molina, J-M., Saillard, J., Moecklinghoff, C., Stellbrink, H-J., Van Leeuwen, R., Gatell, J., Sandstrom, E., Flepp, M., Ewings, F., George, E. C., Hudson, F., Michal Odermarsky & on behalf of the NEAT 001/ANRS 143 Study Group, 2016 Apr 1, In : Journal of Antimicrobial Chemotherapy. 71, 4, p. 1056-1062 7 p., dkv427.

    Research output: Contribution to journalArticle

  8. NLF20: an antimicrobial peptide with therapeutic potential against invasive Pseudomonas aeruginosa infection.

    Praveen Papareddy, Kasetty, G., Kalle, M., Ravi Bhongir, Mörgelin, M., Artur Schmidtchen & Malmsten, M., 2016, In : Journal of Antimicrobial Chemotherapy. 71, 1, p. 170-180

    Research output: Contribution to journalArticle

  9. 2014
  10. 2013
  11. Outer membrane vesicles shield Moraxella catarrhalis β-lactamase from neutralization by serum IgG.

    Schaar, V., Magnus Paulsson, Mörgelin, M. & Kristian Riesbeck, 2013, In : Journal of Antimicrobial Chemotherapy. 68, 3, p. 593-600

    Research output: Contribution to journalArticle

  12. 2012
  13. The epithelium-produced growth factor midkine has fungicidal properties.

    Nordin, S., Sonesson, A., Malmsten, M., Mörgelin, M. & Arne Egesten, 2012, In : Journal of Antimicrobial Chemotherapy. 67, 8, p. 1927-1936

    Research output: Contribution to journalArticle

  14. 2010
  15. Combinations of maggot excretions/secretions and antibiotics are effective against Staphylococcus aureus biofilms and the bacteria derived therefrom

    Mariena J.A. van der Plas, Dambrot, C., Dogterom-Ballering, H. C. M., Kruithof, S., van Dissel, J. T. & Nibbering, P. H., 2010 Feb 26, In : Journal of Antimicrobial Chemotherapy. 65, 5, p. 917-923 7 p., dkq042.

    Research output: Contribution to journalArticle

  16. Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data

    Angeby, K. A., Jureen, P., Giske, C. G., Chryssanthou, E., Erik Sturegård, Nordvall, M., Johansson, A. G., Werngren, J., Kahlmeter, G., Hoffner, S. E. & Schon, T., 2010, In : Journal of Antimicrobial Chemotherapy. 65, 5, p. 946-952

    Research output: Contribution to journalArticle

  17. 2009
  18. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis

    Schon, T., Jureen, P., Giske, C. G., Chryssanthou, E., Erik Sturegård, Werngren, J., Kahlmeter, G., Hoffner, S. E. & Angeby, K. A., 2009, In : Journal of Antimicrobial Chemotherapy. 64, 4, p. 786-793

    Research output: Contribution to journalArticle

  19. 2008
  20. Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa

    Mariena J.A. Van der Plas, Jukema, G. N., Wai, S. W., Dogterom-Ballering, H. C. M., Lagendijk, E. I., Van Gulpen, C., Van Dissel, J. T., Bloemberg, G. V. & Nibbering, P. H., 2008 Jan, In : Journal of Antimicrobial Chemotherapy. 61, 1, p. 117-122 6 p.

    Research output: Contribution to journalArticle

  21. 2007
  22. Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner

    Sandrini, M. P. B., Clausen, A. R., On, S. L. W., Aarestrup, F. M., Munch-Petersen, B. & Piskur, J., 2007, In : Journal of Antimicrobial Chemotherapy. 60, 3, p. 510-520

    Research output: Contribution to journalArticle

  23. 2006
  24. Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation

    Kronvall, G., Karlsson, I., Mats Walder, Sorberg, M. & Nilsson, LE., 2006, In : Journal of Antimicrobial Chemotherapy. 57, 3, p. 498-505

    Research output: Contribution to journalArticle

  25. Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids

    Baranska-Rybak, W., Sonesson, A., Nowicki, R. & Artur Schmidtchen, 2006, In : Journal of Antimicrobial Chemotherapy. 57, 2, p. 260-265

    Research output: Contribution to journalArticle

  26. 2005
  27. Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry

    Pina-Vaz, C., Rodrigues, AG., Costa-de-Oliveira, S., Ricardo, E. & Per-Anders Mårdh, 2005, In : Journal of Antimicrobial Chemotherapy. 56, 4, p. 678-685

    Research output: Contribution to journalArticle

  28. 2004
  29. Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model.

    Kruszewska, D., Sahl, H-G., Bierbaum, G., Pag, U., Hynes, S. & Ljungh, Å., 2004, In : Journal of Antimicrobial Chemotherapy. 54, 3, p. 648-653

    Research output: Contribution to journalArticle

  30. Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer

    Werthen, M., Davoudi, M., Sonesson, A., Nitsche, P., Mörgelin, M., Blom, K. & Artur Schmidtchen, 2004, In : Journal of Antimicrobial Chemotherapy. 54, 4, p. 772-779

    Research output: Contribution to journalArticle

  31. 2002
  32. 1998
  33. 1996
  34. Identification of mecA-related oxacillin resistance in staphylococci by the E test and the broth microdilution method

    Petersson, A. C., Miörner, H. & Kamme, C., 1996, In : Journal of Antimicrobial Chemotherapy. 37, 3, p. 445-456

    Research output: Contribution to journalArticle

  35. 1993
  36. Recurrent episodes of thrombocytopenia during treatment with sodium stibogluconate

    Braconier, J. H. & Miörner, H., 1993, In : Journal of Antimicrobial Chemotherapy. 31, 1, p. 187-188

    Research output: Contribution to journalLetter